BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
578 hedge funds and large institutions have $2.03B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2020 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 110 increasing their positions, 216 reducing their positions, and 103 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
578
Holders Change
-37
Holders Change %
-6.02%
% of All Funds
12.77%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.27%
New
76
Increased
110
Reduced
216
Closed
103
Calls
$27.1M
Puts
$1.37M
Net Calls
+$25.7M
Net Calls Change
-$14.2M
